Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress
Go back to Lilly reports second-quarter 2026 financial results, raises full-year guidance, and highlights continued growth and pipeline progress| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1144.69 +28.99 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1115.70 | 52 Week High | $88.16 | |||
| Open | $1142.20 | 52 Week Low | $67.88 | |||
| Day High | $1153.95 | P/E | 264.97 | |||
| Day Low | $1130.50 | EPS | $4.32 | |||
| Volume | 782,923 | |||||

